Deletion in lymphocytic leukemia 1 (DLEU1) enhances cancer stemness by upgrading upregulating stem cell markers (SOX2, OCT4, NANOG, and KLF4) in cholangiocarcinoma. Here, DLEU1 is linked to cancer.